548 related articles for article (PubMed ID: 15240877)
1. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
[TBL] [Abstract][Full Text] [Related]
2. Generation of monoclonal antibody that distinguishes PrPSc from PrPC and neutralizes prion infectivity.
Horiuchi M; Karino A; Furuoka H; Ishiguro N; Kimura K; Shinagawa M
Virology; 2009 Nov; 394(2):200-7. PubMed ID: 19766283
[TBL] [Abstract][Full Text] [Related]
3. Modification of blood cell PrP epitope exposure during prion disease.
Thackray AM; Ryder SJ; Bujdoso R
Biochem J; 2005 Sep; 390(Pt 2):563-71. PubMed ID: 15885031
[TBL] [Abstract][Full Text] [Related]
4. Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein.
Thackray AM; Madec JY; Wong E; Morgan-Warren R; Brown DR; Baron T; Bujdoso R
Biochem J; 2003 Feb; 370(Pt 1):81-90. PubMed ID: 12429022
[TBL] [Abstract][Full Text] [Related]
5. Prion (PrPSc)-specific epitope defined by a monoclonal antibody.
Korth C; Stierli B; Streit P; Moser M; Schaller O; Fischer R; Schulz-Schaeffer W; Kretzschmar H; Raeber A; Braun U; Ehrensperger F; Hornemann S; Glockshuber R; Riek R; Billeter M; Wüthrich K; Oesch B
Nature; 1997 Nov; 390(6655):74-7. PubMed ID: 9363892
[TBL] [Abstract][Full Text] [Related]
6. Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies.
Kim CL; Umetani A; Matsui T; Ishiguro N; Shinagawa M; Horiuchi M
Virology; 2004 Mar; 320(1):40-51. PubMed ID: 15003861
[TBL] [Abstract][Full Text] [Related]
7. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
8. Immunoaffinity purification and neutralization of scrapie prions.
Gabizon R; McKinley MP; Groth D; Westaway D; DeArmond SJ; Carlson GA; Prusiner SB
Prog Clin Biol Res; 1989; 317():583-600. PubMed ID: 2574871
[TBL] [Abstract][Full Text] [Related]
9. Epitope scanning reveals gain and loss of strain specific antibody binding epitopes associated with the conversion of normal cellular prion to scrapie prion.
Pan T; Li R; Kang SC; Wong BS; Wisniewski T; Sy MS
J Neurochem; 2004 Sep; 90(5):1205-17. PubMed ID: 15312175
[TBL] [Abstract][Full Text] [Related]
10. Insight into the PrPC-->PrPSc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants.
Eghiaian F; Grosclaude J; Lesceu S; Debey P; Doublet B; Tréguer E; Rezaei H; Knossow M
Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10254-9. PubMed ID: 15240887
[TBL] [Abstract][Full Text] [Related]
11. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
[TBL] [Abstract][Full Text] [Related]
12. Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.
Horiuchi M; Caughey B
EMBO J; 1999 Jun; 18(12):3193-203. PubMed ID: 10369660
[TBL] [Abstract][Full Text] [Related]
13. PrP glycoforms are associated in a strain-specific ratio in native PrPSc.
Khalili-Shirazi A; Summers L; Linehan J; Mallinson G; Anstee D; Hawke S; Jackson GS; Collinge J
J Gen Virol; 2005 Sep; 86(Pt 9):2635-2644. PubMed ID: 16099923
[TBL] [Abstract][Full Text] [Related]
14. Antibody binding defines a structure for an epitope that participates in the PrPC-->PrPSc conformational change.
Kanyo ZF; Pan KM; Williamson RA; Burton DR; Prusiner SB; Fletterick RJ; Cohen FE
J Mol Biol; 1999 Nov; 293(4):855-63. PubMed ID: 10543972
[TBL] [Abstract][Full Text] [Related]
15. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
16. A novel epitope for the specific detection of exogenous prion proteins in transgenic mice and transfected murine cell lines.
Vorberg I; Buschmann A; Harmeyer S; Saalmüller A; Pfaff E; Groschup MH
Virology; 1999 Mar; 255(1):26-31. PubMed ID: 10049818
[TBL] [Abstract][Full Text] [Related]
17. Species-specificity of a panel of prion protein antibodies for the immunohistochemical study of animal and human prion diseases.
Furuoka H; Yabuzoe A; Horiuchi M; Tagawa Y; Yokoyama T; Yamakawa Y; Shinagawa M; Sata T
J Comp Pathol; 2007 Jan; 136(1):9-17. PubMed ID: 17270205
[TBL] [Abstract][Full Text] [Related]
18. Molecular biology and genetics of prion diseases.
Prusiner SB
Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):447-63. PubMed ID: 7913765
[TBL] [Abstract][Full Text] [Related]
19. Prion-protein-specific aptamer reduces PrPSc formation.
Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
[TBL] [Abstract][Full Text] [Related]
20. Conformational variation between allelic variants of cell-surface ovine prion protein.
Thackray AM; Yang S; Wong E; Fitzmaurice TJ; Morgan-Warren RJ; Bujdoso R
Biochem J; 2004 Jul; 381(Pt 1):221-9. PubMed ID: 15070397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
